Worth reading
53Recurring
Scored from 2 of 5 sectionsDirection
Neutral
Direction inferred from the company’s description.Scale
0
SharesWording
Definitive
How definitive the wording is.Details of issuance or disposal
8th and 9th Stock Acquisition Rights issued through a third-party allotment (with exercise price adjustment clauses)
発行済株式総数
Exercise ratio for the month: 0.00% for the 8th series and 0.00% for the 9th series. Exercise ratio subject to exercise restrictions: 0%
The dilution rate shows what proportion the newly issued shares represent of the existing shares. The higher the proportion, the more the value and voting rights per share are diluted.
Terms of the stock acquisition rights
Exercise price
Series 8: ¥2,757; Series 9: ¥3,192. Details of the adjustment provisions and the adjustment floor: not disclosed
Number of Stock Acquisition Rights
Total issued: not disclosed. Unexercised balance as of the end of the month preceding the subject month: Series 8, 2,340 rights (234,000 shares); Series 9, 727 rights (72,700 shares). Unexercised balance as of the end of the subject month: Series 8, 2,340 rights (234,000 shares); Series 9, 727 rights (72,700 shares)
Procedures under the Corporate Code of Conduct
Describes compliance with the exercise restrictions under Article 434 of the Tokyo Stock Exchange's Securities Listing Regulations and the Japan Securities Dealers Association's Rules Concerning the Handling of Third-Party Allotments and Other Matters
Most recent equity financing
Timing 7 April 2022 / Type 8th and 9th Stock Acquisition Rights issued through a third-party allotment (with exercise price adjustment clauses) / Amount Not disclosed
| Item | Details |
|---|---|
| Type of issuance or disposal | 8th and 9th Stock Acquisition Rights issued through a third-party allotment (with exercise price adjustment clauses) |
| Dilution Rate | Exercise ratio for the month: 0.00% for the 8th series and 0.00% for the 9th series. Exercise ratio subject to exercise restrictions: 0% |
| Total number of issued shares | 2,787,100 shares (as of the end of the month preceding the subject month) → 2,787,100 shares (estimated to be as of the end of the subject month, although not explicitly stated) |
| Exercise price | Series 8: ¥2,757; Series 9: ¥3,192. Details of the adjustment provisions and the adjustment floor: not disclosed |
| Number of Stock Acquisition Rights | Total issued: not disclosed. Unexercised balance as of the end of the month preceding the subject month: Series 8, 2,340 rights (234,000 shares); Series 9, 727 rights (72,700 shares). Unexercised balance as of the end of the subject month: Series 8, 2,340 rights (234,000 shares); Series 9, 727 rights (72,700 shares) |
| Procedures under the Corporate Code of Conduct | Describes compliance with the exercise restrictions under Article 434 of the Tokyo Stock Exchange's Securities Listing Regulations and the Japan Securities Dealers Association's Rules Concerning the Handling of Third-Party Allotments and Other Matters |
| Most recent equity financing | Timing 7 April 2022 / Type 8th and 9th Stock Acquisition Rights issued through a third-party allotment (with exercise price adjustment clauses) / Amount Not disclosed |
Items this document does not state (21)
Number of shares to be issued or disposed ofIssue price and disposal priceTotal issue valueAmount of funds to be raisedEstimated issuance expensesSpecific use of fundsPayment dateIntended allotteeIntended allottee's holding policyBasis for determining the amount to be paidExercise periodTransfer restriction periodConditions for lifting transfer restrictionsReason for acquisition without considerationCategories and Number of Persons CoveredTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioMajor shareholders after the offeringImpact on Business Performance
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.This was a report on the monthly exercise status; no reason was given for the lack of exercises.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.